MARKETING INVESTIGATIONS OF THE UKRAINIAN PHARMACEUTICAL MARKET OF MEDICINES FOR LOCAL TREATMENT OF ACNE AND DEMODICOSIS

Список авторов:

Davtian L. L. Dr. Pharm. Sciences, Prof., Head of the Department of Pharmaceutical Technology and biopharmatics of the NMAPO named after P. L. Shupyk Drozdova A. O. Dr. Pharm. Mr., Associate Professor, Department of Pharmaceutical Technology and Biopharmacy of NMAPO named after P. L. Shupyk Koval A. S. Postgraduate student of the chair of pharmaceutical technology and biopharmacy of NMAPO named after P. L. Shupyk National Medical Academy of Postgraduate Education named after P. L. Shupyk Kyiv, Ukraine

Анотация:

Introduction: Today, the problem of treatment
and rehabilitation of patients with demodex, rosacea,
perioral dermatitis and acne is very relevant, as there is
an increase in morbidity among people of working age,
requirements for appearance as a factor [3, 4] are in-
creased, which plays an important role in professional
and personal success in society. As a result of the
chronic inflammatory process on the face of the skin
formed defects resistant to most methods of external
therapy and cosmetic correction. Cosmetic defects af-
fect socio-psychological, interpersonal relationships,
often cause feelings of anxiety, depression, and lower
quality of life of patients, which makes this problem
relevant not only in the medical, but also in the social
aspect [6, 7].

Ключевые слова:

Key words: producer countries, local therapy, acne, demodicosis,dermatology, cream, gel, ointment. View Fullscreen

Библиография:

Reference:
1. Erhan Zeytun and Yücel Karakurt, Preva-
lence and Load of Demodex folliculorum and Demo-
dex brevis (Acari: Demodicidae) in Patients With
Chronic Blepharitis in the Province of Erzincan, Tur-
key , Journal of Medical Entomology,
10.1093/jme/tjy143, 56, 1, (2-9), (2018).
2. F.M.N. Forton and V. De Maertelaer, Pap-
ulopustular rosacea and rosacea‐like demodicosis: two
phenotypes of the same disease?, Journal of the Euro-
pean Academy of Dermatology and Venereology, 32,
6, (1011-1016), (2018).
3. B. Diczig, I. Nemeth, V. Sardy and G. Po-
nyai, Contact hypersensitivity in rosacea – a report on
1143 cases, Journal of the European Academy of Der-
matology and Venereology, 32, 9,(e347-t349), (2018)
4. N. Lacey, A. Russell‐Hallinan, C.C. Zou-
boulis and F.C. Powell, Demodex mites modulate sebo-
cyte immune reaction: possible role in the pathogenesis
of rosacea, British Journal of Dermatology, 179, 2,
(420-430), (2018).
5. Anna D. Holmes and Martin Steinhoff, Inte-
grative concepts of rosacea pathophysiology, clinical
presentation and new therapeutics, Experimental Der-
matology, 26, 8, (659-667), (2016).
6. Osnovni trendy rozvytku
farmatsevtychnoho rynku Ukrainy po
farmakoterapevtychnykh hrupakh / Za redaktsiieiu L.
L. Davtian, R. S. Korytniuk, H. M. Voitenko – K.:
Osvita Ukrainy, 2015. – 130 s.
7. Vlasenko I. O. Porivnialnyi analiz rynku
dermatolohichnykh likarskykh zasobiv v Ukraini za
2013 ta 2018 rr. / I. O. Vlasenko, L. L. Davtian //
Zbirnyk naukovykh prats spivrobitnykiv NMAPO im.
P. L. Shupyka. — 2018. — Vyp. 29. — S. 194-205.